IntegriChain Acquires Cumberland's Life Sciences Division
April 13, 2020
IntegriChain has acquired the Life Sciences Division of Cumberland, adding the division's employees and assets to its data and managed services platform for market access, contracts, pricing and revenue management. The deal expands IntegriChain's customer base to more than 220 life sciences manufacturers (including 20 of the top 20) and grows the combined team to over 350 professionals; Lincoln International arranged debt financing and Clearsight Advisors advised Cumberland on the sale.
- Buyers
- IntegriChain
- Targets
- Cumberland Life Sciences Division
- Sellers
- Cumberland
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Tegria Acquires Cumberland
March 16, 2021
Healthcare Services
Tegria, a healthcare technology and services company launched by Providence, has acquired Cumberland, a Franklin, Tennessee–based healthcare consulting and managed services firm with more than 250 employees. The acquisition expands Tegria's consulting capabilities for payer organizations, strengthens its managed services for providers, and will have Cumberland operate as an independent business unit within Tegria's consulting and technology services group.
-
IntegriChain Acquires BridgeView Data Solutions
June 18, 2024
Data & Analytics
IntegriChain has acquired the commercial data warehouse and data aggregation assets (DataBridge) of BridgeView Life Sciences LLC, integrating BridgeView's AI-assisted data exploration and field intelligence into IntegriChain’s ICyte platform. The deal expands IntegriChain's commercial data capabilities for pharmaceutical manufacturers and is the company's sixth acquisition and first since partnering with private equity backer Nordic Capital.
-
Nordic Capital Acquires Majority Stake in IntegriChain from Accel-KKR
November 8, 2023
Cloud & SaaS
Nordic Capital has agreed to acquire a majority share in IntegriChain, a Philadelphia-based provider of a data-driven commercialization and market-access platform for the pharmaceutical industry, from Accel-KKR. The terms were not disclosed; closing is expected before year-end and is subject to customary regulatory and closing conditions.
-
IntegriChain Acquires Blue Fin Group
January 20, 2022
Consulting
IntegriChain has acquired Blue Fin Group, a life-sciences focused management consulting firm that specializes in market access, commercialization strategy, and patient services. The deal brings Blue Fin's team of consultants into IntegriChain as an independent division to combine IntegriChain's ICyte data and application platform with Blue Fin's commercialization expertise, expanding end-to-end therapy launch and market access capabilities.
-
IntegriChain Acquires Federal Compliance Solutions
July 9, 2024
Healthcare Services
IntegriChain has acquired Federal Compliance Solutions (FCS), a life‑sciences advisory and managed‑services firm focused on government pricing, contracting, and gross‑to‑net. The deal expands IntegriChain’s outsourcing and advisory capabilities, bringing FCS’s team of more than 60 professionals into IntegriChain’s ~750‑person global organization to deepen contracts & pricing and gross‑to‑net offerings for pharmaceutical manufacturers.
-
Trinity Life Sciences Acquires CBPartners
October 7, 2021
Healthcare Services
Trinity Life Sciences has acquired New York–headquartered CBPartners to significantly scale its Value, Access and Pricing business, adding over 75 dedicated experts and expanding Trinity's presence in New York City, San Francisco and London. The acquisition augments Trinity's market access, pricing and commercial strategy capabilities to better support life sciences companies in bringing products to market and ensuring patient access globally.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.